-
hcup-us.ahrq.gov/reports/factsandfigures/figures/2005/2005_3_4.jsp
January 01, 2005 - Cardiovascular Procedures
Number of Inpatient Hospital Cardiovascular Procedures, 1993-2005
-
hcup-us.ahrq.gov/reports/projections/2012-02.pdf
January 01, 2012 - HCUP Projections:
Cardiovascular/Cerebrovascular Conditions and Procedures 2001 to 2012. 2012. … • cardiovascular/cerebrovascular system procedures, overall
• four specific cardiovascular/cerebrovascular … The
cardiovascular/cerebrovascular conditions and procedures reported in this study are identified … Cardiac Projections
Return to Contents
Cardiovascular/Cerebrovascular Procedures
Cardiovascular … procedures
• 63 Other non-OR therapeutic cardiovascular procedures
HCUP Projections:
Cardiovascular
-
hcup-us.ahrq.gov/toolssoftware/comorbidity/Table1-FY2006-V3_1.pdf
December 01, 2006 - MAJOR CV DX Cardiac
554 OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX Cardiac
555 PERCUTANEOUS CARDIOVASCULAR … PERCUTANEOUS CARDIOVASC PROC W
NON-DRUG-ELUTING STENT W/O MAJ CV
DX
Cardiac
557
PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR
CV DX
Cardiac
558
PERCUTANEOUS CARDIOVASCULAR
PROC W DRUG-ELUTING
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsV20WeightsManual.pdf
January 06, 2025 - Procedures with AMI) and 517
(Percutaneous Cardiovascular Procedures without AMI, with Coronary Artery … with AMI
527
Percutaneous Cardiovascular Procedure with Drug-Eluding Stent
without AMI
The … procedure that would quality them for assignment to DRG
517 (Percutaneous Cardiovascular Procedure … Procedure with Drug-Eluting Stent
with AMI
516 Percutaneous Cardiovascular Procedures with AMI … 527
Percutaneous Cardiovascular Procedure with Drug-Eluting Stent
without AMI
517 Percutaneous Cardiovascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb241-Coronary-Artery-AMI-Stroke-Hospital-Stays-2001-2014.pdf
January 01, 2014 - Introduction
Atherosclerotic cardiovascular disease (ASCVD) refers to disease
of the heart and blood … ASCVD can limit blood flow to the heart (coronary artery disease)
and lead to dangerous cardiovascular … Cardiovascular Disease: A Costly Burden for America,
Projections Through 2035. 2017. www.heart.org/idc … Adult ASCVD inpatient stays with common cardiovascular procedures, 2001–2014
Abbreviations: ASCVD … The largest variation
between the two cardiovascular procedures occurred among ASCVD stays with CABG
-
hcup-us.ahrq.gov/reports/statbriefs/sb171-Operating-Room-Procedure-Trends.jsp
March 01, 2014 - Two common cardiovascular procedures decreased from 2001—2011. … OR procedures involving the cardiovascular system decreased from 15.5 percent of all OR procedures in … system
44: Coronary artery bypass graft (CABG)
Cardiovascular system
45: Percutaneous … procedures
Cardiovascular system
Figure 5: Other vascular OR procedures
51: Endarterectomy … , vessel of head and neck
Cardiovascular system
55: Peripheral vascular bypass
Cardiovascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb171-Operating-Room-Procedure-Trends.pdf
September 01, 2013 - ■ Two common cardiovascular
procedures decreased from
2001–2011. … OR procedures involving the cardiovascular system
decreased from 15.5 percent of all OR procedures in … (PTCA) Cardiovascular system
48: Cardiac pacemaker or cardioverter/defibrillator
procedures Cardiovascular … system
Figure 5: Other vascular
OR procedures
51: Endarterectomy, vessel of head and neck Cardiovascular … system
55: Peripheral vascular bypass Cardiovascular system
Figure 6: OR procedures
related to
-
hcup-us.ahrq.gov/reports/statbriefs/sb234-Adverse-Drug-Events.pdf
June 01, 2016 - caused by
smooth muscle and respiratory
drugs (up 24 percent) and
decreased the most for ADEs
caused by cardiovascular … Rate of stays decreased most
for cardiovascular drugs;
average costs and length of stay
increased … for ADEs caused by
smooth muscle and respiratory drugs and decreased the most for ADEs caused by
cardiovascular … The largest decreases were for cardiovascular drugs (down 46.2 percent), agents affecting blood
constituents … drugs Digoxin, antiadrenergics, and other cardiovascular drugs
Water, mineral, and uric acid metabolism
-
hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR-ChangeLog-v20231-v20241.xlsx
December 01, 2023 - Bioprosthetic Valve into Inferior Vena Cava, Percutaneous Approach, New Technology Group 9 'CAR029' Cardiovascular … Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9 'CAR029' Cardiovascular … Device, Bioprosthetic Valve into Right Femoral Vein, Open Approach, New Technology Group 9 'CAR029' Cardiovascular … Device, Bioprosthetic Valve into Left Femoral Vein, Open Approach, New Technology Group 9 'CAR029' Cardiovascular … XXE2X19 Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9 'MAM010' Other cardiovascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb109.jsp
April 01, 2011 -
Systemic agents not elsewhere classified‡
2,900
0.1%
10,800
1.1%
5
6
Cardiovascular … related adverse outcomes within age group. 17 and under; psychotropics, 8.1%; antibiotics, 16.0%; cardiovascular … Cardiovascular drugs were a common cause of drug-related adverse outcomes in children and in those patients … 13.0%; 65 and older; systemic agents; 0%; other antiinfectives, 0%; agents effecting blood, 14.2%; cardiovascular … E933.0
Systemic agents not elsewhere classified‡
963.8, 963.9, E858.1, E933.8, E933.9
Cardiovascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb234-Adverse-Drug-Events.jsp
January 01, 2018 - Rate of stays decreased most for cardiovascular drugs; average costs and length of stay increased most … Cardiovascular drugs: -46.2% originated during stay, 0.7% present on admission. … Cardiovascular drugs: 34.3% originated during stay, 22.7% present on admission. … Cardiovascular drugs: 29.4% originated during stay, 7.4% present on admission. … drugs
Digoxin, antiadrenergics, and other cardiovascular drugs
Water, mineral, and uric acid
-
hcup-us.ahrq.gov/reports/infographics/AHRQ-HCUP-Outpatient-Surgery-Infographic-v06f.pdf
March 04, 2015 - AHRQ-HCUP-Outpatient-Surgery-Infographic-v06f
Obstetric Surgeries: 97.7%
Cardiovascular Surgeries:
-
hcup-us.ahrq.gov/reports/factsandfigures/figures/2005/2005_4_1B.jsp
January 01, 2005 - Diagnoses
Amount and Growth in Inflation-adjusted* Hospitalization Costs for Six of the Most Costly Cardiovascular
-
hcup-us.ahrq.gov/db/vars/prccsr_aaannn/kidnote.jsp
September 01, 2008 - Each clinical domain is abbreviated using a three-character scheme such as CAR for Cardiovascular Procedures … PRCCSR_CAR003 indicates CCSR category for Coronary artery bypass grafts (CABG) under the clinical domain of Cardiovascular
-
hcup-us.ahrq.gov/db/vars/prccsr_aaannn/nisnote.jsp
September 01, 2008 - Each clinical domain is abbreviated using a three-character scheme such as CAR for Cardiovascular Procedures … PRCCSR_CAR003 indicates CCSR category for Coronary artery bypass grafts (CABG) under the clinical domain of Cardiovascular
-
hcup-us.ahrq.gov/db/vars/prccsr_aaannn/nedsnote.jsp
May 01, 2015 - Each clinical domain is abbreviated using a three-character scheme such as CAR for Cardiovascular Procedures … PRCCSR_CAR003 indicates CCSR category for Coronary artery bypass grafts (CABG) under the clinical domain of Cardiovascular
-
hcup-us.ahrq.gov/db/vars/prccsr_aaannn/nrdnote.jsp
August 01, 2015 - Each clinical domain is abbreviated using a three-character scheme such as CAR for Cardiovascular Procedures … PRCCSR_CAR003 indicates CCSR category for Coronary artery bypass grafts (CABG) under the clinical domain of Cardiovascular
-
hcup-us.ahrq.gov/reports/factsandfigures/2008/pdfs/section4_1.pdf
January 01, 2008 - Five of the twenty most expensive conditions were cardiovascular: coronary atherosclerosis, acute … With the exception of costs of stays for cardiac dysrhythmias, the costs for these cardiovascular
-
hcup-us.ahrq.gov/reports/natstats/his95/table2a.htm
February 11, 2011 - Operations on the nose,
mouth, and pharynx Operations on the
respiratory system Operations on the
cardiovascular … ___________________________________________________________________________
7 Operations on the cardiovascular … 0.45 $30,021 $8,948 $16,429 $32,200 8.5 5.1 53.2 60
7.20 Other diagnostic cardiovascular … 0.11 $13,993 $6,795 $10,619 $16,771 5.9 0.9 56.8 62
7.21 Other non-OR therapeutic cardiovascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb109.pdf
April 01, 2011 - , such as anticoagulants; systemic agents, such as antineoplastic and immunosuppressive
drugs; and cardiovascular … agents
Sedatives and hypnotics
Diuretics other than saluretics
Other agents primarly affecting the cardiovascular … -r
el
at
ed
a
dv
er
se
ou
tc
om
es
w
ith
in
a
ge
g
ro
up
Psychotropics Antibiotics
Cardiovascular … Cardiovascular drugs were a common cause of drug-
related adverse outcomes in children and in those patients … E942.4
Antilipemics 972.2, E942.2
Other and unspecified agents primarily affecting the
cardiovascular